Founder and Chief Executive Officer

Dr. Roland Ong

Dr. Roland Ong, is the founder of Nanyang Biologics. He has witnessed many cancer patients including his father-in-law being cured by the South East Asia Medicinal plants that are now currently used in our R&D.

Science and Technology Chair

Ravindran Govindan

His career expanded into various business interests, including property development and spearheading IPOs. Notably, he served as Executive Chairman and President of Fisher Scientific Inc. for the Asia Pacific region. With 45 years of expertise, he founded Mercatus Capital in 2006, focusing on nurturing and investing in start-ups specializing in emerging technologies. Mr. Ravi’s visionary leadership and mentorship have been instrumental in guiding numerous start-ups to success, particularly in healthcare innovation. Additionally, he provides legal and business consultancy services to private and public enterprises, including Latona Associates Inc, a New York-based investment firm.

Director

Kelvin Wu

Kelvin is an international entrepreneur and philanthropist with over 27 years in investment banking and private equity. He is the chairman of AID Partners. Under his management, AID  developed world fastest diagnostic kit for rapid detection of COVID-19.  Prior to founding AID, he was the President of Investec Asia, Managing Director of China Everbright Capital.

Chief Operation Officer

Dr. Winifred Yau, Ph.D.

Dr. Yau holds a Ph.D. in medicine and graduate certificate in intellectual property law. She was a research fellow in Duke-NUS Medical School specializing in metabolic disorders. Her unique blend of scientific and legal expertise equips her to lead the company towards innovative healthcare solutions and scientific breakthroughs.

Chief Strategy and Planning

Micheal Fong

Michael has 29 years’ experience in international business, operations, and technology. Mr. Fong invests in, manages, and advises companies in pharmaceuticals, healthcare and biotech including areas of plant-based medicines, digital health and AI-powered healthcare diagnostics. Previously, Mr. Fong held leadership roles as the Managing Director & VP for Asia for Blizzard Entertainment and the Managing Director for Activision Blizzard International.

Chief Scientific Officer

Dr. Yi Chieh Lim, Ph.D.

Dr. Lim is an entrepreneurial scientist specializing in cancer pharmacology and healthcare solutions. Dr. Lim holds a Ph.D. in Medicine and was previously a Senior Fellow at the Danish Cancer Society

​

Chief Technology Officer

Giang Nguyen

As our Chief Technology Officer, Mr. Nguyen will spearhead our AI-driven drug discovery platform. With a robust background as a pioneering entrepreneur and technologist passionate about the potential of artificial intelligence, he brings invaluable expertise to revolutionize healthcare through innovative AI applications.

Clinical and Scientific Advisor

Prof. Izhak Haviv, Ph.D.

Prof. Haviv is a molecular pathologist spending 25+ years in translational medicine. He was an Associate Professor in the University of Melbourne, Peter MacCallum Cancer Center and has previously worked on drugs like Herceptin and Keytruda.

Nanyang Biologics-NTU Joint Lab

Prof. Hoi Yeung Li, Ph.D.

Prof. Li is the lead scientist and co-director at the Nanyang Biologics-NTU joint lab. He completed his post-doctoral research at the Howard Hughes Medical Institute. He specializes in cancer biology, mitotic catastrophe in cancer treatment, and natural product-inspired drug development using tropical medicinal plants.

Business Development Advisor

Patrick Lee, Ph.D.

Dr. Lee is the business development advisor of Nanyang Biologics. He has extensive experience in business development.